國立虎尾科技大學 |

Atypical Breast Proliferative Lesions and Benign Breast Disease

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Atypical Breast Proliferative Lesions and Benign Breast Disease / edited by Farin Amersi, Kristine Calhoun.
other author:	Amersi, Farin.
Description:	XI, 197 p. 28 illus., 24 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Surgery. -
Online resource:	https://doi.org/10.1007/978-3-319-92657-5
ISBN:	9783319926575

Atypical Breast Proliferative Lesions and Benign Breast Disease
Atypical Breast Proliferative Lesions and Benign Breast Disease [electronic resource] /edited by Farin Amersi, Kristine Calhoun. - 1st ed. 2018. - XI, 197 p. 28 illus., 24 illus. in color.online resource.

The Spectrum of Risk Lesions in Breast Pathology: Risk Factors or Cancer Precursors? -- Lobular Carcinoma In Situ: Risk Factor or Cancer Precursor? -- Ductal Carcinoma In Situ: Risk Factor or Cancer -- Diagnostic Management of Papillomas, Radial Scars, and Flat Epithelial Atypia: Core Biopsy Alone Versus Core Biopsy Plus Excision -- Diagnostic Management of Fibroepithelial Lesions: When Is Excision Indicated? -- Diagnostic Management of the Atypical Hyperplasias: Core Biopsy Alone vs Excisional Biopsy -- Diagnostic management of LCIS: Core biopsy alone versus core biopsy plus excision for classic versus pleomorphic LCIS -- Breast Cancer Risk Prediction in Women with Atypical Breast Lesions -- Advanced Screening Options and Surveillance in Women with Atypical Breast Lesions -- The Role of Chemoprevention in the Prevention of Breast Cancer -- Prophylactic Mastectomy in Patients with Atypical Breast Lesions -- The Non-surgical Management of Ductal Carcinoma in Situ (DCIS) -- Surgical Treatment of Ductal Carcinoma in Situ. .

The days of surgical excision for any atypical lesion have been replaced by more nuanced decision making and individualized patient management. Current management of many of these lesions continues to be controversial in regard to observation with close surveillance versus the need for surgical excision of these lesions based on future risk or whether these lesions are precursor lesion. The goal of this book is to provide a concise but comprehensive review of atypical breast proliferative lesions and their management complexities. New data about breast cancer, risk factors for breast cancer, pathological features unique to each entity, the characteristic findings on imaging, risk stratification for genetic testing, as well as the current evidence-based management of each of these breast lesions are discussed in full detail. Assessment tools for risk prediction of breast cancer are also highlighted as chapters run the gamut of current imaging modalities, as well as advanced screening options available for diagnosis and following these patients. Atypical Breast Proliferative Lesions and Benign Breast Disease will undoubtedly become a valuable resource for nurse practitioners, physician assistants, breast and surgical oncology fellows, genetic counselors, geneticists, as well as other clinicians and surgeons who are referred and manage these complex breast patients. All chapters in this text are written by experts in the field who have research and clinical interest in each of these disease entities, and include the most up-to-date research and clinical information to enhance our understanding and treatment of patients.

ISBN: 9783319926575

Standard No.: 10.1007/978-3-319-92657-5doiSubjects--Topical Terms:

644132
Surgery.

LC Class. No.: RD1-811

Dewey Class. No.: 617

Atypical Breast Proliferative Lesions and Benign Breast Disease
LDR:04033nam a22003975i 4500 001 990668
003 DE-He213
005 20200706224702.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319926575 $9 978-3-319-92657-5
024 7 $a 10.1007/978-3-319-92657-5 $2 doi
035 $a 978-3-319-92657-5
050 4 $a RD1-811
072 7 $a MNC $2 bicssc
072 7 $a MED085000 $2 bisacsh
072 7 $a MNC $2 thema
082 0 4 $a 617 $2 23
245 1 0 $a Atypical Breast Proliferative Lesions and Benign Breast Disease $h [electronic resource] / $c edited by Farin Amersi, Kristine Calhoun.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a XI, 197 p. 28 illus., 24 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a The Spectrum of Risk Lesions in Breast Pathology: Risk Factors or Cancer Precursors? -- Lobular Carcinoma In Situ: Risk Factor or Cancer Precursor? -- Ductal Carcinoma In Situ: Risk Factor or Cancer -- Diagnostic Management of Papillomas, Radial Scars, and Flat Epithelial Atypia: Core Biopsy Alone Versus Core Biopsy Plus Excision -- Diagnostic Management of Fibroepithelial Lesions: When Is Excision Indicated? -- Diagnostic Management of the Atypical Hyperplasias: Core Biopsy Alone vs Excisional Biopsy -- Diagnostic management of LCIS: Core biopsy alone versus core biopsy plus excision for classic versus pleomorphic LCIS -- Breast Cancer Risk Prediction in Women with Atypical Breast Lesions -- Advanced Screening Options and Surveillance in Women with Atypical Breast Lesions -- The Role of Chemoprevention in the Prevention of Breast Cancer -- Prophylactic Mastectomy in Patients with Atypical Breast Lesions -- The Non-surgical Management of Ductal Carcinoma in Situ (DCIS) -- Surgical Treatment of Ductal Carcinoma in Situ. .
520 $a The days of surgical excision for any atypical lesion have been replaced by more nuanced decision making and individualized patient management. Current management of many of these lesions continues to be controversial in regard to observation with close surveillance versus the need for surgical excision of these lesions based on future risk or whether these lesions are precursor lesion. The goal of this book is to provide a concise but comprehensive review of atypical breast proliferative lesions and their management complexities. New data about breast cancer, risk factors for breast cancer, pathological features unique to each entity, the characteristic findings on imaging, risk stratification for genetic testing, as well as the current evidence-based management of each of these breast lesions are discussed in full detail. Assessment tools for risk prediction of breast cancer are also highlighted as chapters run the gamut of current imaging modalities, as well as advanced screening options available for diagnosis and following these patients. Atypical Breast Proliferative Lesions and Benign Breast Disease will undoubtedly become a valuable resource for nurse practitioners, physician assistants, breast and surgical oncology fellows, genetic counselors, geneticists, as well as other clinicians and surgeons who are referred and manage these complex breast patients. All chapters in this text are written by experts in the field who have research and clinical interest in each of these disease entities, and include the most up-to-date research and clinical information to enhance our understanding and treatment of patients.
650 0 $a Surgery. $3 644132
650 0 $a Surgical oncology. $3 1254222
650 0 $a Oncology . $3 1253469
650 0 $a Pathology. $3 668553
650 1 4 $a General Surgery. $3 673829
650 2 4 $a Surgical Oncology. $3 673742
650 2 4 $a Oncology. $3 593951
700 1 $a Amersi, Farin. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1209670
700 1 $a Calhoun, Kristine. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1209671
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319926568
776 0 8 $i Printed edition: $z 9783319926582
776 0 8 $i Printed edition: $z 9783030064822
856 4 0 $u https://doi.org/10.1007/978-3-319-92657-5
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)